- Home
- HLMN vs DNLI Comparison
HLMN vs DNLI Comparison
Compare HLMN & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLMN
- DNLI
- Stock Information
- Founded
- HLMN 1964
- DNLI 2013
- Country
- HLMN United States
- DNLI United States
- Employees
- HLMN N/A
- DNLI N/A
- Industry
- HLMN Industrial Machinery/Components
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HLMN Consumer Discretionary
- DNLI Health Care
- Exchange
- HLMN Nasdaq
- DNLI Nasdaq
- Market Cap
- HLMN 2.2B
- DNLI 1.8B
- IPO Year
- HLMN N/A
- DNLI 2017
- Fundamental
- Price
- HLMN $7.63
- DNLI $12.74
- Analyst Decision
- HLMN Buy
- DNLI Strong Buy
- Analyst Count
- HLMN 5
- DNLI 16
- Target Price
- HLMN $11.50
- DNLI $37.57
- AVG Volume (30 Days)
- HLMN 1.7M
- DNLI 1.7M
- Earning Date
- HLMN 04-29-2025
- DNLI 05-06-2025
- Dividend Yield
- HLMN N/A
- DNLI N/A
- EPS Growth
- HLMN N/A
- DNLI N/A
- EPS
- HLMN 0.09
- DNLI N/A
- Revenue
- HLMN $1,472,595,000.00
- DNLI N/A
- Revenue This Year
- HLMN $5.94
- DNLI N/A
- Revenue Next Year
- HLMN $4.49
- DNLI $372.05
- P/E Ratio
- HLMN $86.72
- DNLI N/A
- Revenue Growth
- HLMN N/A
- DNLI N/A
- 52 Week Low
- HLMN $7.24
- DNLI $10.57
- 52 Week High
- HLMN $12.08
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- HLMN 35.46
- DNLI 42.15
- Support Level
- HLMN $7.43
- DNLI $12.37
- Resistance Level
- HLMN $7.93
- DNLI $13.63
- Average True Range (ATR)
- HLMN 0.42
- DNLI 1.24
- MACD
- HLMN -0.02
- DNLI 0.23
- Stochastic Oscillator
- HLMN 21.91
- DNLI 50.94
About HLMN Hillman Solutions Corp.
Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the group are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the US, Canada and Mexico.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.